OneAscent Financial Services’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$266K Sell
951
-942
-50% -$254K 0.26% 103
2020
Q4
$464K Buy
1,893
+265
+16% +$68.4K 0.5% 40
2020
Q3
$462K Sell
1,628
-617
-27% -$172K 0.24% 81
2020
Q2
$601K Buy
2,245
+141
+7% +$42.4K 0.4% 41
2020
Q1
$666K Sell
2,104
-968
-32% -$294K 0.5% 17
2019
Q4
$912K Buy
+3,072
New +$852K 0.5% 14
2019
Q3
Sell
-3,313
Closed -$775K 39
2019
Q2
$775K Buy
+3,313
New +$765K 0.53% 21

Other funds holding BIIB

OneAscent Financial Services's BIIB Position: Q1 2021 in Review

OneAscent Financial Services reduced its Biogen (BIIB) stake by 50% in Q1 2021, selling an estimated $254K and leaving 951 shares worth $266K. The position accounts for 0.26% of the portfolio, ranked #103.

OneAscent Financial Services first reported a position in BIIB in Q2 2019 and has held it in 7 quarters since. The position peaked at $912K in Q4 2019. 1,094 funds tracked by Wall St. Rank hold BIIB as of Q1 2021.

  • OneAscent Financial Services held 951 shares of Biogen worth $266K as of Q1 2021.
  • OneAscent Financial Services sold 942 Biogen shares in Q1 2021, an estimated $254K.
  • Biogen made up 0.26% of OneAscent Financial Services's portfolio in Q1 2021, its #103 holding.
  • OneAscent Financial Services first reported a position in Biogen in Q2 2019 and has held it in 7 quarters since.
  • OneAscent Financial Services's Biogen position peaked at $912K in Q4 2019.
  • 1,094 funds tracked by Wall St. Rank held Biogen as of Q1 2021.

Based on OneAscent Financial Services's 13F filing for Q1 2021, filed 27 Apr 2021.